Wockhardt is planning to raise funds through issuance of Non-Convertible Debentures (NCDs) on private placement basis. The meeting of the Credit Facilities Committee of the Board of Directors of the Company is scheduled to be held on April 21, 2021, inter-alia, to consider and approve the proposal for raising of funds.
Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.